4L53
Crystal Structure of (1R,4R)-4-{4-[7-amino-2-(1,2,3-benzothiadiazol-7-yl)-3-chlorofuro[2,3-c]pyridin-4-yl]-1H-pyrazol-1-yl}cyclohexan-1-ol bound to TAK1-TAB1
Summary for 4L53
Entry DOI | 10.2210/pdb4l53/pdb |
Related | 4L3P 4L52 |
Descriptor | Mitogen-activated protein kinase kinase kinase 7, TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 chimera, trans-4-{4-[7-amino-2-(1,2,3-benzothiadiazol-7-yl)-3-chlorofuro[2,3-c]pyridin-4-yl]-1H-pyrazol-1-yl}cyclohexanol, 1,2-ETHANEDIOL, ... (4 entities in total) |
Functional Keywords | tak1 kinase, transferase-transferase inhibitor complex, transferase/transferase inhibitor |
Biological source | Homo sapiens (human) More |
Total number of polymer chains | 1 |
Total formula weight | 35300.12 |
Authors | Wang, J.,Hornberger, K.R.,Crew, A.P.,Jestel, A.,Maskos, K.,Moertl, M. (deposition date: 2013-06-10, release date: 2013-07-03, Last modification date: 2024-02-28) |
Primary citation | Hornberger, K.R.,Chen, X.,Crew, A.P.,Kleinberg, A.,Ma, L.,Mulvihill, M.J.,Wang, J.,Wilde, V.L.,Albertella, M.,Bittner, M.,Cooke, A.,Kadhim, S.,Kahler, J.,Maresca, P.,May, E.,Meyn, P.,Romashko, D.,Tokar, B.,Turton, R. Discovery of 7-aminofuro[2,3-c]pyridine inhibitors of TAK1: Optimization of kinase selectivity and pharmacokinetics. Bioorg.Med.Chem.Lett., 23:4511-4516, 2013 Cited by PubMed: 23856049DOI: 10.1016/j.bmcl.2013.06.054 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.55 Å) |
Structure validation
Download full validation report